House To Probe FDA Knowledge Of Ranbaxy Fraud
Leaders from a U.S. House of Representatives Committee on Energy and Commerce said Thursday that they plan to launch an investigation into whether the U.S. Food and Drug Administration knowingly let...To view the full article, register now.
Already a subscriber? Click here to view full article